| High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa FY Tso, SJ Lidenge, PB Peña, AA Clegg, JR Ngowi, J Mwaiselage, ... International Journal of Infectious Diseases 102, 577-583, 2021 | 220 | 2021 |
| Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review O Ngalamika, Y Zhang, H Yin, M Zhao, ME Gershwin, Q Lu Journal of autoimmunity 39 (4), 451-465, 2012 | 80 | 2012 |
| Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials SK Korang, E Von Rohden, AA Veroniki, G Ong, O Ngalamika, F Siddiqui, ... PLoS One 17 (1), e0260733, 2022 | 69 | 2022 |
| Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections O Ngalamika, G Liang, M Zhao, X Yu, Y Yang, H Yin, Y Liu, S Yung, ... Immunological investigations 44 (2), 126-136, 2015 | 54 | 2015 |
| RNA-Seq of Kaposi’s sarcoma reveals alterations in glucose and lipid metabolism FY Tso, AV Kossenkov, SJ Lidenge, O Ngalamika, JR Ngowi, ... PLoS pathogens 14 (1), e1006844, 2018 | 50 | 2018 |
| DNA hypermethylation leads to lower FOXP3 expression in CD4+ T cells of patients with primary Sjögren's syndrome X Yu, G Liang, H Yin, O Ngalamika, F Li, M Zhao, Q Lu Clinical immunology 148 (2), 254-257, 2013 | 45 | 2013 |
| Comatose and noncomatose adult diabetic ketoacidosis patients at the University Teaching Hospital, Zambia: Clinical profiles, risk factors, and mortality outcomes M Kakusa, B Kamanga, O Ngalamika, S Nyirenda Indian journal of endocrinology and metabolism 20 (2), 199-205, 2016 | 24 | 2016 |
| Similar immunological profiles between african endemic and human immunodeficiency virus type 1–associated epidemic Kaposi Sarcoma (KS) patients reveal the primary role of KS … SJ Lidenge, FY Tso, O Ngalamika, JR Ngowi, Y Mortazavi, EH Kwon, ... The Journal of infectious diseases 219 (8), 1318-1328, 2019 | 23 | 2019 |
| Kaposi’s sarcoma at the University Teaching Hospital, Lusaka, Zambia in the antiretroviral therapy era O Ngalamika, V Minhas, C Wood International journal of cancer. Journal international du cancer 136 (5), 1241, 2015 | 22 | 2015 |
| Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis SJ Lidenge, AV Kossenkov, FY Tso, J Wickramasinghe, SR Privatt, ... PLoS pathogens 16 (7), e1008681, 2020 | 16 | 2020 |
| Lack of CD8+ T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors SJ Lidenge, FY Tso, O Ngalamika, J Kolape, JR Ngowi, J Mwaiselage, ... Oncotarget 11 (17), 1556, 2020 | 16 | 2020 |
| Screening for diabetes mellitus among tuberculosis patients: findings from a study at a Tertiary Hospital in Lusaka, Zambia S Fwoloshi, LM Hachaambwa, KO Chiyeñu, L Chirwa, TW Hoffman, ... Canadian Journal of Infectious Diseases and Medical Microbiology 2018, 2018 | 16 | 2018 |
| Therapeutic outcomes in AIDS-associated Kaposi's sarcoma patients on antiretroviral therapy treated with chemotherapy at two tertiary hospitals in Lusaka, Zambia W Mtonga, A Mujajati, D Munkombwe, A Kalungia, LT Muungo, J West, ... Current HIV research 16 (3), 231-236, 2018 | 13 | 2018 |
| Impact of musculoskeletal symptoms on physical functioning and quality of life among treated people with HIV in high and low resource settings: a case study of the UK and Zambia NS Van de Ven, O Ngalamika, K Martin, KA Davies, JH Vera Plos one 14 (5), e0216787, 2019 | 11 | 2019 |
| Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence O Ngalamika, MC Mukasine, M Kawimbe, F Vally PLoS One 16 (7), e0254177, 2021 | 9 | 2021 |
| Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma O Ngalamika, FY Tso, S Lidenge, S Munsaka, D Shea, C Wood, J West PLoS One 15 (7), e0235865, 2020 | 9 | 2020 |
| SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study O Ngalamika, SJ Lidenge, MC Mukasine, M Kawimbe, P Kamanzi, ... International Journal of Infectious Diseases 127, 106-115, 2023 | 8 | 2023 |
| Antiretroviral therapy for HIV-associated cutaneous kaposi's sarcoma: clinical, HIV-related, and sociodemographic predictors of outcome O Ngalamika, S Munsaka, SJ Lidenge, JT West, C Wood AIDS research and human retroviruses 37 (5), 368-372, 2021 | 8 | 2021 |
| Admitted AIDS-associated Kaposi sarcoma patients: Indications for admission and predictors of mortality F Vally, WMP Selvaraj, O Ngalamika Medicine 99 (39), e22415, 2020 | 8 | 2020 |
| A 27-year-old severely immunosuppressed female with misleading clinical features of disseminated cutaneous sporotrichosis A Patel, V Mudenda, S Lakhi, O Ngalamika Case Reports in Dermatological Medicine 2016, 2016 | 8 | 2016 |
